Cargando…

Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia

BACKGROUND: Mesenchymal stem cells (MSCs) at maternal-fetal interface are considered to play an important role in the pathogenesis of pre-eclampsia (PE). microRNAs (miRNAs) also have an important influence on differentiation, maturation, and functions of MSCs. Our aim in this study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Guangfeng, Zhou, Xue, Chen, Shiwen, Miao, Huishuang, Fan, Hongye, Wang, Zhiqun, Hu, Yali, Hou, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237795/
https://www.ncbi.nlm.nih.gov/pubmed/25135655
http://dx.doi.org/10.1186/s12929-014-0081-3
_version_ 1782345397690171392
author Zhao, Guangfeng
Zhou, Xue
Chen, Shiwen
Miao, Huishuang
Fan, Hongye
Wang, Zhiqun
Hu, Yali
Hou, Yayi
author_facet Zhao, Guangfeng
Zhou, Xue
Chen, Shiwen
Miao, Huishuang
Fan, Hongye
Wang, Zhiqun
Hu, Yali
Hou, Yayi
author_sort Zhao, Guangfeng
collection PubMed
description BACKGROUND: Mesenchymal stem cells (MSCs) at maternal-fetal interface are considered to play an important role in the pathogenesis of pre-eclampsia (PE). microRNAs (miRNAs) also have an important influence on differentiation, maturation, and functions of MSCs. Our aim in this study was to determine the differential expression of miRNAs in decidua-derived MSCs (dMSCs) from severe PE and normal pregnancies. RESULTS: miRNA expression profiles in dMSCs from five patients with severe PE and five healthy pregnant women were screened using microarray. Then, bioinformatic analysis of the microarray results was performed. Out of 179 differentially expressed miRNAs, 49 miRNAs had significant (p < 0.05) differential expression of ≥ 2.0-fold changes, including 21 up-regulated and 28 down-regulated. miRNA-Gene-network and miRNA-Gene ontology (GO) -network analyses were performed. Overall, 21 up-regulated and 15 down-regulated miRNAs showed high degrees in these analyses. Moreover, the significantly enriched signaling pathways and GOs were identified. The analyses revealed that pathways associated with cell proliferation, angiogenesis, and immune functions were highly regulated by the differentially expressed miRNAs, including Wnt signaling pathway, mitogen-activated protein kinase signaling pathway, transforming growth factor beta signaling pathway, T-cell receptor signaling pathway, and B cell receptor signaling pathway. Four miRNA predicted target genes, vascular endothelial growth factor A (VEGFA), indoleamine 2,3-dioxygenase, suppression of cytokine signaling 3, and serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B α isoform (PPP2R2A) were all decreased in dMSCs from patients with PE. Furthermore, the physiological roles of miR-16 and miR-136 in the down-regulation of VEGFA and PPP2R2A, respectively, were confirmed through reporter assays. CONCLUSIONS: These findings suggest that miRNAs in dMSCs may be important regulatory molecules in the development of PE.
format Online
Article
Text
id pubmed-4237795
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42377952014-11-21 Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia Zhao, Guangfeng Zhou, Xue Chen, Shiwen Miao, Huishuang Fan, Hongye Wang, Zhiqun Hu, Yali Hou, Yayi J Biomed Sci Research BACKGROUND: Mesenchymal stem cells (MSCs) at maternal-fetal interface are considered to play an important role in the pathogenesis of pre-eclampsia (PE). microRNAs (miRNAs) also have an important influence on differentiation, maturation, and functions of MSCs. Our aim in this study was to determine the differential expression of miRNAs in decidua-derived MSCs (dMSCs) from severe PE and normal pregnancies. RESULTS: miRNA expression profiles in dMSCs from five patients with severe PE and five healthy pregnant women were screened using microarray. Then, bioinformatic analysis of the microarray results was performed. Out of 179 differentially expressed miRNAs, 49 miRNAs had significant (p < 0.05) differential expression of ≥ 2.0-fold changes, including 21 up-regulated and 28 down-regulated. miRNA-Gene-network and miRNA-Gene ontology (GO) -network analyses were performed. Overall, 21 up-regulated and 15 down-regulated miRNAs showed high degrees in these analyses. Moreover, the significantly enriched signaling pathways and GOs were identified. The analyses revealed that pathways associated with cell proliferation, angiogenesis, and immune functions were highly regulated by the differentially expressed miRNAs, including Wnt signaling pathway, mitogen-activated protein kinase signaling pathway, transforming growth factor beta signaling pathway, T-cell receptor signaling pathway, and B cell receptor signaling pathway. Four miRNA predicted target genes, vascular endothelial growth factor A (VEGFA), indoleamine 2,3-dioxygenase, suppression of cytokine signaling 3, and serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B α isoform (PPP2R2A) were all decreased in dMSCs from patients with PE. Furthermore, the physiological roles of miR-16 and miR-136 in the down-regulation of VEGFA and PPP2R2A, respectively, were confirmed through reporter assays. CONCLUSIONS: These findings suggest that miRNAs in dMSCs may be important regulatory molecules in the development of PE. BioMed Central 2014-08-19 /pmc/articles/PMC4237795/ /pubmed/25135655 http://dx.doi.org/10.1186/s12929-014-0081-3 Text en Copyright © 2014 Zhao et al.; licensee BioMed Central http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhao, Guangfeng
Zhou, Xue
Chen, Shiwen
Miao, Huishuang
Fan, Hongye
Wang, Zhiqun
Hu, Yali
Hou, Yayi
Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title_full Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title_fullStr Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title_full_unstemmed Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title_short Differential expression of microRNAs in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
title_sort differential expression of micrornas in decidua-derived mesenchymal stem cells from patients with pre-eclampsia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237795/
https://www.ncbi.nlm.nih.gov/pubmed/25135655
http://dx.doi.org/10.1186/s12929-014-0081-3
work_keys_str_mv AT zhaoguangfeng differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT zhouxue differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT chenshiwen differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT miaohuishuang differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT fanhongye differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT wangzhiqun differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT huyali differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia
AT houyayi differentialexpressionofmicrornasindeciduaderivedmesenchymalstemcellsfrompatientswithpreeclampsia